ConvaTec Group Stock Price, News & Analysis (OTCMKTS:CNVVY) $11.28 0.00 (0.00%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$11.28▼$11.2850-Day Range$9.95▼$11.6652-Week Range$9.90▼$12.23Volume25 shsAverage Volume1,035 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesShort Interest About ConvaTec Group Stock (OTCMKTS:CNVVY)ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.Read More CNVVY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNVVY Stock News HeadlinesNovember 1, 2023 | msn.comConvaTec Group Plc - ADR (CNVVY) Price Target Increased by 11.65% to 14.42October 30, 2023 | nypost.comNavy deploys warships to Mediterranean Sea near Israel following Hamas attackDecember 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!September 8, 2023 | marketwatch.comConvaTec Group Says Sten Scheibye to Step Down From BoardAugust 16, 2023 | msn.comConvaTec Group goes ex-dividend tomorrowAugust 3, 2023 | marketwatch.comConvaTec Group PLC 1H Rev $1.06BJuly 22, 2023 | finance.yahoo.comConvaTec Group PLC: Convatec Makes Small Steps Toward Progress on Its TurnaroundJuly 6, 2023 | finance.yahoo.comConvaTec Group PLC: Convatec: Steady Improvements in Innovation and Execution Should Add Up to Improved ReturnsDecember 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!May 18, 2023 | marketwatch.comConvaTec Raises 2023 Sales ViewMay 2, 2023 | finance.yahoo.comConvaTec Group PLC (LON:CTEC) Stock's On A Decline: Are Poor Fundamentals The Cause?May 1, 2023 | finance.yahoo.comConvaTec Group PLC: ConvaTec Pushes Forward With Turnaround PlanMarch 9, 2023 | finance.yahoo.comConvaTec Group Plc: ConvaTec Delivered More Turnaround Progress in 2022; No Change to Our Fair Value EstimateMarch 9, 2023 | marketwatch.comConvaTec Group PLC FY Rev $2.07BMarch 8, 2023 | marketwatch.comConvaTec Group's 2022 Profit Set to Slip Despite Revenue Rise -- Earnings PreviewJanuary 12, 2023 | ca.finance.yahoo.comConvaTec Group Plc (CNVVF)September 29, 2022 | finance.yahoo.comConvaTec Group Plc: We're Reducing ConvaTec's Uncertainty Rating, but Our Fair Value Estimate Is UnchangedAugust 23, 2022 | finance.yahoo.comConvaTec Group (LON:CTEC) Has More To Do To Multiply In Value Going ForwardAugust 17, 2022 | uk.finance.yahoo.comConvatec Group PLC: Director/PDMR ShareholdingJuly 1, 2022 | finance.yahoo.comInsiders who bought into ConvaTec Group Plc (LON:CTEC) earlier this year might wish they'd invested more as stock gained 4.9%May 13, 2022 | finance.yahoo.comConvaTec Group Plc: ConvaTec Starts 2022 in Strong Fashion and Hints at Strategic Ambitions; Shares Remain UndervaluedMay 1, 2022 | wsj.comConvaTec Group PLC ADRApril 18, 2022 | finance.yahoo.comConvaTec Group Plc's (LON:CTEC) Intrinsic Value Is Potentially 29% Above Its Share PriceFebruary 21, 2022 | morningstar.comConvaTec Group PLC ADR CNVVYJanuary 19, 2022 | finance.yahoo.comConvaTec Group Plc: ConvaTec Faces Ongoing Coronavirus Pressure, but Its End Markets Remain AttractiveJanuary 7, 2022 | finance.yahoo.comAre ConvaTec Group Plc's (LON:CTEC) Mixed Financials Driving The Negative Sentiment?December 9, 2021 | marketwatch.comConvaTec Group CFO to Step Down in MarchSee More Headlines Receive CNVVY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 10/13 Dividend8/17/2023Dividend Payable10/13/2023Today12/01/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CNVVY CUSIPN/A CIK1694271 Webwww.convatecgroup.com Phone441189528100FaxN/AEmployees10,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Karim Bitar (Age 58)CEO & Director Comp: $3.05MMr. Jonathan Peter Mason (Age 59)Group CFO & Director Comp: $1.32MMr. John HallerExecutive VP and Chief Quality & Operations OfficerDr. Divakar Ramakrishnan Ph.D.Executive VP, Chief Technology Officer and Head of Research & DevelopmentMs. Kate PostansVice President of Investor Relations & Corporate CommunicationsMs. Evelyn Douglas J.D.Executive VP, Chief of Corporate Strategy & Business Development and General CounselMs. Natalia KozminaExecutive VP, Chief Human Resources Officer & ESG StewardshipMs. Kjersti Grimsrud Biotechnology (Age 62)M.Sc., President & COO of Infusion Care Mr. Supratim Bose (Age 71)President & COO of Global Emerging Markets Mr. David ShepherdPresident & COO of Global Advanced Wound CareMore ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors CNVVY Stock Analysis - Frequently Asked Questions Should I buy or sell ConvaTec Group stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNVVY shares. View CNVVY analyst ratings or view top-rated stocks. How have CNVVY shares performed in 2023? ConvaTec Group's stock was trading at $11.11 at the start of the year. Since then, CNVVY shares have increased by 1.5% and is now trading at $11.28. View the best growth stocks for 2023 here. Are investors shorting ConvaTec Group? ConvaTec Group saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 300 shares, an increase of 200.0% from the October 31st total of 100 shares. Based on an average daily trading volume, of 1,400 shares, the days-to-cover ratio is currently 0.2 days. View ConvaTec Group's Short Interest. How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group? ConvaTec Group declared a dividend on Thursday, August 3rd. Stockholders of record on Friday, August 18th will be given a dividend of $0.0561 per share on Friday, October 13th. The ex-dividend date of this dividend is Thursday, August 17th. Read our dividend analysis for CNVVY. Is ConvaTec Group a good dividend stock? ConvaTec Group (OTCMKTS:CNVVY) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for CNVVY. How do I buy shares of ConvaTec Group? Shares of CNVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:CNVVY) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.